News
Eisai & Biogen announce update on regulatory review of MAA for lecanemab to treat early Alzheimer’s disease by European Commission: Tokyo Wednesday, April 16, 2025, 11:00 Hrs [I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback